Status:

UNKNOWN

ARTERIAL EMBOLIZATION OF PERSISTENT GENICULATE ARTERIES FOR CHRONIC PAIN MANAGEMENT AFTER TOTAL KNEE-REPLACEMENT ARTHROPLASTY(KNEE EMBOLISATION)

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Musculoskeletal Inflammatory

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Recent works in interventional radiology have shown interesting results in the treatment of musculoskeletal inflammatory sites by arterial embolization. Supra-selective arterial embolization has been ...

Detailed Description

Hypothesis: Selective arterial embolization of persistent geniculate arteries could reduce chronic post-operative gonalgia after TKA with minimally invasive approach. Objective: To evaluate the feasi...

Eligibility Criteria

Inclusion

  • Adult patient (male or female) aged 18-85
  • Suffering from moderate to severe chronic pain (EVA \> 50mm) more than 6 months after total prosthetic knee replacement surgery for severe gonarthrosis with impact on quality of life.
  • And having followed for at least 3 months a well-conducted conservative medical treatment (anti-inflammatory, analgesic, masso-kinesiotherapy).
  • The patient may initially have had a single or bilateral replacement. The period of 6 months must be respected for each side, between the intervention and the inclusion for homolateral pain.
  • Patient willing to participate in the study and with signed informed consent.
  • Patient willing to undergo post-operative monitoring for one year.

Exclusion

  • Orthopaedic or rheumatological pathologies:
  • Rheumatoid arthritis
  • Psoriatic rheumatism
  • Spondylarthropathies
  • History of primary or secondary bone tumor, in remission or active.
  • Myeloma
  • Operational criteria:
  • Infection of the surgical site
  • Re-operation
  • Severe bleeding
  • Use of turnstile per-operative
  • Wound of popliteal artery
  • Diabetic patient
  • Comorbidities:
  • General condition responsible for objective hemostasis disorder (hemophilia, Willebrand disease, thrombocytopenia) and anticoagulant treatments.
  • Pads 100 G/L

Key Trial Info

Start Date :

June 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2024

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04417686

Start Date

June 22 2021

End Date

February 1 2024

Last Update

August 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hopitaux de Marseille

Marseille, France, 13354